Literature DB >> 23820434

Beliefs underlying the intention to donate again among first-time blood donors who experience a mild adverse event.

Barbara M Masser1, Katherine M White, Deborah J Terry.   

Abstract

Using the belief basis of the theory of planned behavior (TPB), the current study explored the rate of mild reactions reported by donors in relation to their first donation and the intention and beliefs of those donors with regard to returning to donate again. A high proportion of first-time donors indicated that they had experienced a reaction to blood donation. Further, donors who reacted were less likely to intend to return to donate. Regression analyses suggested that targeting different beliefs for those donors who had and had not reacted would yield most benefit in bolstering donors' intentions to remain donating. The findings provide insight into those messages that could be communicated via the mass media or in targeted communications to retain first-time donors who have experienced a mild vasovagal reaction.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Keywords:  Adverse event; First-time donors; Theory of planned behavior; Vasovagal reaction

Mesh:

Year:  2013        PMID: 23820434     DOI: 10.1016/j.transci.2013.06.008

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN: 1473-0502            Impact factor:   1.764


  3 in total

Review 1.  Donor research in australia: challenges and promise.

Authors:  Barbara Masser; Geoff Smith; Lisa A Williams
Journal:  Transfus Med Hemother       Date:  2014-07-04       Impact factor: 3.747

2.  Translation into Portuguese and validation of the Blood Donation Reactions Inventory.

Authors:  Ana Carolina Garcia Braz; Rodrigo Guimarães Dos Santos Almeida; Edson Zangiacomi Martinez
Journal:  Rev Bras Hematol Hemoter       Date:  2014-03

3.  Joint effects of risk factors on adverse events associated with adult blood donations.

Authors:  Hsuan-Hui Wang; Po-Ming Chen; Chi-Ling Lin; Rong-Chiou Jau; Sheng-Mou Hsiao; Jiunn-Liang Ko
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.